Session Statistics
| Abstract Totals |
Count |
| Abstracts Submitted |
4923 |
| Presentation |
2574 (52.3%) |
- Oral Presentation (Plenary, Clinical Science
Symposium, Oral Abstract Session) |
258 (10% of total presented) |
|
- Poster Presentation (Poster Discussion,
General Poster, Trials in Progress)
|
2303 (90% of total presented) |
| Publish Only |
1796 |
| Rejected |
324 |
Abstract Submissions by Country
| Demographic Statistics |
|
| United States |
2151 (43.7%) |
| Italy |
668 |
| Germany |
244 |
| Japan |
227 |
| France |
189 |
| Canada |
188 |
| United Kingdom |
149 |
| China |
147 |
| Spain |
138 |
| South Korea |
74 |
| Australia |
59 |
| Turkey |
56 |
Abstract Submissions by Track
| Track |
Submitted |
Accepted for Presentation |
| Breast Cancer - HER2/ER |
275 |
137 |
| Breast Cancer - Triple Negative/ Cytotoxics/ Local Therapy |
212 |
135 |
| Cancer Prevention/Epidemiology |
144 |
102 |
| Central Nervous System Tumors |
132 |
100 |
| Developmental Therapeutics - Clinical Pharmacology & Immunotherapy |
211 |
115 |
| Developmental Therapeutics - Experimental Ther. |
253 |
107 |
| Gastrointestinal (Colorectal) Cancer |
295 |
137 |
| Gastrointestinal (Noncolorectal) Cancer |
312 |
131 |
| Genitourinary Cancer |
369 |
169 |
| Gynecologic Cancer |
205 |
112 |
| Head and Neck Cancer |
134 |
95 |
| Health Services Research |
343 |
141 |
| Leukemia, Myelodysplasia, and Transplantation |
131 |
97 |
| Lung Cancer - Local-Regional and Adjuvant Therapy/ Small Cell |
97 |
92 |
| Lung Cancer - Metastatic/ Non- Small Cell |
229 |
109 |
| Lymphoma and Plasma Cell Disorders |
171 |
86 |
| Melanoma/Skin Cancers |
105 |
96 |
| Patient and Survivor Care |
406 |
139 |
| Pediatric Oncology |
81 |
81 |
| Sarcoma |
140 |
99 |
| Tumor Biology |
318 |
294 |
| Trials in Progress |
360 |
N/A |
| Total |
4923 |
2574 |